Excitingly, more pronounced tumor growth inhibition is observed (131% TGI) in the MCF7 xenograft model, accompanied by significant reductions in ER protein levels when combined with a CDK4/6 inhibitor palbociclib. Here, ESR1 is linked to neoplasm.